The flexible combination and synergy of these modules enable UC-MSCs to intelligently adapt to diverse disease microenvironments, such as NF-κB inhibition in psoriasis (34) and mitochondrial transfer in osteoarthritis (35), demonstrating unique context-dependent therapeutic advantages. The gene discussed is NFKB1; the disease is psoriasis.